Muromonab-CD3 administered in clinical trials with basiliximab with no increase in adverse reactions.
Source: NLP:basiliximab
1 interaction on record
Muromonab-CD3 administered in clinical trials with basiliximab with no increase in adverse reactions.
Source: NLP:basiliximab